Nasal spray for moderate-to-severe seasonal allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new nasal spray (PG-011) for adults with moderate-to-severe seasonal allergies (hay fever). It compares the spray to a placebo to see if it reduces nasal symptoms like stuffiness, sneezing, and runny nose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have had moderate-to-severe seasonal allergies (hay fever) for at least 2 years.
- You have a positive allergy skin or blood test within the last year.
- You do not have moderate-to-severe asthma, active tuberculosis, or other serious lung infections.
- You are willing to avoid pregnancy or fathering children during the study and for 3 months after.
- You have not used certain allergy medications (like antihistamines, steroid sprays, or decongestants) recently without a doctor's OK.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This trial tests a new drug called AK139 for people with seasonal allergies (hay fever) that are not well controlled by standard treatments like nasal sprays. It aims to see if the drug can improve symptoms during pollen season.
This trial tests whether acupuncture at a specific spot behind the nose can reduce symptoms from seasonal allergies (triggered by things like grass or birch pollen). It may help if your allergy symptoms are moderate to severe and have lasted for a long time.
This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.
This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.
This trial tests a new biologic medicine (injection) to see if it can better control seasonal allergy symptoms in teens who haven't had good relief from standard treatments like nasal sprays.
Hear when a new Seasonal Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.